Table 2. Overall survival and median survival of 1522 lung cancer patients stratified by treatment interval from surgery to chemotherapy.
| Characteristic | Group 1(n = 153) | Group 2(n = 261) | Group 3(n = 290) | Group 4(n = 818) | p |
|---|---|---|---|---|---|
| Overall survival rate | <0.0001 | ||||
| One-year | 0.88 (0.82–0.92) | 0.88 (0.84–0.92) | 0.87 (0.83–0.91) | 0.80 (0.77–0.83) | |
| Three-year | 0.57 (0.48–0.64) | 0.64 (0.58–0.70) | 0.65 (0.58–0.70) | 0.50 (0.46–0.53) | |
| Five-year | 0.41 (0.31–0.5) | 0.48 (0.41–0.55) | 0.50 (0.43–0.57) | 0.35 (0.31–0.39) | |
| Median survival (months) | 44.50 (34.70–61.30) | 59.53 (44.63–86.06) | 67.33 (50.33–76.83) | 36.33 (32.17–42.77) | <0.0001 |